Works matching IS 01145916 AND DT 2025 AND VI 48 AND IP 2

Results: 8

Fracture-Related Safety Reporting of JAK Inhibitors: An Analysis from the WHO Global VigiBase: Fracture Risk of JAK Inhibitors: A. M.-De la Torre et al.
Published in:
Drug Safety, 2025, v. 48, n. 2, p. 191, doi. 10.1007/s40264-024-01490-w
By:
- Martinez de la Torre, Adrian;
- Clausen, Andreas Bech;
- Burden, Andrea M.;
- Weiler, Stefan
Publication type:
Article
Views on the Development and Use of a New Digital Adverse Drug Event Reporting Platform in Australia: A Qualitative Study: Views on an Adverse Drug Event Reporting Platform : E.A. Gebreyohannes et al.
Published in:
Drug Safety, 2025, v. 48, n. 2, p. 179, doi. 10.1007/s40264-024-01489-3
By:
- Gebreyohannes, Eyob Alemayehu;
- Thornton, Christopher;
- Thiessen, Myra;
- de Vries, Sieta T.;
- Coombs, Gretchen;
- Hwang, Indae;
- Lim, Renly
Publication type:
Article
Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk Mitigation: Teratogenic Risk Impact and Mitigation (TRIM) Study Protocol: A. G. Winterstein et al.
Published in:
Drug Safety, 2025, v. 48, n. 2, p. 107, doi. 10.1007/s40264-024-01488-4
By:
- Winterstein, Almut G.;
- Ewig, Celeste L. Y.;
- Wang, Yanning;
- Smolinski, Nicole E.;
- Toyserkani, Gita A.;
- LaCivita, Cynthia;
- Lackey, Leila;
- Eggers, Sara;
- Zhou, Esther H.;
- Diaby, Vakaramoko;
- Sarayani, Amir;
- Thai, Thuy;
- Maro, Judith C.;
- Rasmussen, Sonja A.
Publication type:
Article
Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study: Challenges in Implementing EU Risk Minimisation Measures in Clinical Practice Guidelines: M. Møllebæk et al
Published in:
Drug Safety, 2025, v. 48, n. 2, p. 161, doi. 10.1007/s40264-024-01487-5
By:
- Møllebæk, Mathias;
- Gardarsdottir, Helga;
- Bikou, Alexia-Georgia;
- Kodrič, Ana;
- Silva, Ana Marta;
- Andersen, Armin;
- Kontogiorgis, Christos;
- Poplavska, Elita;
- Ahmadizar, Fariba;
- Dermiki-Gkana, Foteini;
- Rutkovska, Ieva;
- Vaz, Inês Ribeiro;
- Kos, Mitja;
- Barão, Paula;
- Grupstra, Renske;
- Alves, Teresa Leonardo;
- Almarsdóttir, Anna Birna
Publication type:
Article
Incidence of Idiosyncratic Drug-Induced Liver Injury Caused by Prescription Drugs: Incidence of DILI Caused by Prescription Drugs: V. L. Chen et al.
Published in:
Drug Safety, 2025, v. 48, n. 2, p. 151, doi. 10.1007/s40264-024-01486-6
By:
- Chen, Vincent L.;
- Rockey, Don C.;
- Bjornsson, Einar S.;
- Barnhart, Huiman;
- Hoofnagle, Jay H.
Publication type:
Article
Drug-Induced Hypouricemia: Drug-Induced Hypouricemia: C. B. Salem et al.
Published in:
Drug Safety, 2025, v. 48, n. 2, p. 129, doi. 10.1007/s40264-024-01485-7
By:
- Ben Salem, Chaker;
- Agrebi, Myriam;
- Sahnoun, Dhouha;
- Fathallah, Neila;
- Hmouda, Houssem
Publication type:
Article
Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury: Role of Chemical Analysis in Causality Assessment: D. Halegoua-DeMarzio et al.
Published in:
Drug Safety, 2025, v. 48, n. 2, p. 143, doi. 10.1007/s40264-024-01484-8
By:
- Halegoua-DeMarzio, Dina;
- Navarro, Victor J.;
- Davis, Ashley;
- Ahmad, Jawad;
- Avula, Bharathi;
- Barnhart, Huiman;
- Barritt IV, A. Sidney;
- Bonkovsky, Herbert L.;
- Chen, Vincent L.;
- Choi, Gina;
- Fontana, Robert J.;
- Ghabril, Marwan S.;
- Khan, Ikhlas;
- Koh, Christopher;
- Odin, Joseph;
- Rockey, Don C.;
- Rostami, Hoss;
- Serrano, Jose;
- Sherker, Averell H.;
- Stolz, Andrew
Publication type:
Article
Safeguarding Patients in the AI Era: Ethics at the Forefront of Pharmacovigilance: Ethical Considerations for AI-Driven Pharmacovigilance: A. Jain et al.
Published in:
Drug Safety, 2025, v. 48, n. 2, p. 119, doi. 10.1007/s40264-024-01483-9
By:
- Jain, Ashish;
- Salas, Maribel;
- Aimer, Omar;
- Adenwala, Zahabia
Publication type:
Article